Search for: "B. R." Results 5261 - 5280 of 55,760
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Mar 2015, 4:00 am by Ray Dowd
@ronaldedayDingledy, Fred @ding0036Doty, Paula @pauladotyDumas, Tina @planettinaEiseman, Jason @jeisemanFarrell, Elizabeth @elizabethfFeikert, Clare @itspoppetFeliu, Vicenc @Sabreur76Fitz, Kate @katefitzFrey, Scott @sfreywsuGarcia, Iris @IrisGarciaGiammettei, Jo-Anne @jogiammatteiGierloff, Tami @teegeepdxGinsberg, Debbie @debgpiGlassmeyer, Sarah @sglassmeyerGoitom, Hanibal @HanibalgoitomHall, Christine @chall6Halls, Rachel Scott @rachscotthallsHarrington, R. [read post]
27 Aug 2018, 2:27 pm by Lawrence B. Ebert
§ 42.23(b). (...)The Board’s error was parsing Ericsson’s argumentson reply with too fine of a filter. [read post]
22 Mar 2018, 12:45 pm
Hukuk Dairesinin Yargıtay Cumhuriyet Başsavcılığının kanun yararına bozma kararı ile getirdiği bu içtihat, şirketler ile tüketiciler arasındaki bütün alacak borç ilişkisini yeniden düzenleyecektir. [read post]
7 Oct 2018, 8:48 am by Dennis Crouch
Cal Judge Wu dismissed the case on the pleadings under R.12(b)(6) — finding that the claims of U.S. [read post]
1 Dec 2015, 6:51 am
[+PDF] Tejerina, B., Llopis Goig, R.: Capital Educativo y Precariedad: Cambios Recientes en las Condiciones de Vida en España (1995-2010). 5 (4), 1050-1085. [read post]
28 Feb 2023, 3:20 pm by Jacob Katz Cogan
Reading the Tragedy of International Criminal Justice in Lebanon Critical Review of Governance Natalie R. [read post]
7 Jan 2014, 9:15 am by WSLL
Addleman.Representing Appellee: R. [read post]
1 Oct 2018, 7:47 am
Irrespectively, of how any trade agreements or policy could result in an increase in overseas pricing of pharmaceuticals it is clear that being able to price pharmaceuticals above their marginal cost of production, for example to take account of the cost of R&D, will require the right to exclude third parties (competitors), either through patent protection or similar sui generis protection, from producing or selling (copied) pharmaceutical products. [read post]
24 May 2018, 10:53 am by Suzanne Seay
I’m no actuary, but I’m pretty darn good at math for a regular person.And yet, every time I read a NY policy with an accelerated death benefit that discounts the payment, which is fairly regularly, I have to get out a pencil and a piece of paper and think, think, think.Here’s a very simplified version of how NY describes the interest rate that may be used to figure the discount.The maximum interest rate cannot exceed the greater of:(a) yield on 90-day T-Bills; and(b)… [read post]